Global Topical Pain Relief Market Outlook 2028

Table of Content

Global Topical Pain Relief Market

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Assumptions and Abbreviations

3. Research Methodology
3.1. Research Process
3.2. Secondary Research
3.3. Primary Research
3.4. Market Size Estimation

4. Executive Summary - Global Topical Pain Relief Market

5. Regulatory Landscape

6. Patent Analysis

7. Clinical Trial Analysis

8. Pipeline Analysis

9. Market Dynamics
9.1. Drivers
9.2. Restraints
9.3. Trends
9.4. Opportunities


10. Topical Pain Relief Market - Risk Analysis
10.1. Demand Risk Analysis
10.2. Supply Risk Analysis

11. Global Topical Pain Relief Market Outlook
11.1. Market Size and Forecast, 2018-2027F - By Value (USD Million)
11.1.1. By Therapeutic Class, 2019-2028F (USD MILLION)
11.1.1.1. Non-Opioids, 2019-2028F (USD MILLION)
11.1.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
11.1.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
11.1.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
11.1.1.1.1.3. Others, 2019-2028F (USD MILLION)
11.1.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
11.1.1.1.3. Others, 2019-2028F (USD MILLION)
11.1.1.2. Opioids, 2019-2028F (USD MILLION)
11.1.2. By Type, 2019-2028F (USD MILLION)
11.1.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
11.1.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
11.1.3. By Formulation, 2019-2028F (USD MILLION)
11.1.3.1. Cream & Rubs, 2019-2028F (USD MILLION)

11.1.3.2. Patch, 2019-2028F (USD MILLION)
11.1.3.3. Spray, 2019-2028F (USD MILLION)
11.1.3.4. Gel, 2019-2028F (USD MILLION)
11.1.3.5. Others, 2019-2028F (USD MILLION)
11.1.4. By Distribution Channel, 2019-2028F (USD MILLION)
11.1.4.1. Online, 2019-2028F (USD MILLION)
11.1.4.2. Offline, 2019-2028F (USD MILLION)
11.1.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
11.1.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
11.1.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
11.1.4.2.4. Others, 2019-2028F (USD MILLION)
11.1.5. By Region
11.1.5.1. North America, Europe, Asia Pacific, Latin America, Middle East & Africa

12. North America Topical Pain Relief Market Outlook
12.1. Macro-Economic Indicators impacting the North America Topical Pain Relief Market
12.2. Market Size & Forecast (USD Million)
12.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
12.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
12.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
12.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)

12.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
12.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
12.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
12.2.1.1.3. Others, 2019-2028F (USD MILLION)
12.2.1.2. Opioids, 2019-2028F (USD MILLION)
12.2.2. By Type, 2019-2028F (USD MILLION)
12.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
12.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
12.2.3. By Formulation, 2019-2028F (USD MILLION)
12.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
12.2.3.2. Patch, 2019-2028F (USD MILLION)
12.2.3.3. Spray, 2019-2028F (USD MILLION)
12.2.3.4. Gel, 2019-2028F (USD MILLION)
12.2.3.5. Others, 2019-2028F (USD MILLION)
12.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
12.2.4.1. Online, 2019-2028F (USD MILLION)
12.2.4.2. Offline, 2019-2028F (USD MILLION)
12.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
12.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
12.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)

12.2.4.2.4. Others, 2019-2028F (USD MILLION)
12.2.5. By Country, 2019-2028F (USD MILLION)
12.2.5.1. US, 2019-2028F (USD MILLION)
12.2.5.2. Canada, 2019-2028F (USD MILLION)

13. Europe Topical Pain Relief Market Outlook
13.1. Macro-Economic Indicators impacting the Europe Topical Pain Relief Market
13.2. Market Size & Forecast (USD Million)
13.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
13.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
13.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
13.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
13.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
13.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
13.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
13.2.1.1.3. Others, 2019-2028F (USD MILLION)
13.2.1.2. Opioids, 2019-2028F (USD MILLION)
13.2.2. By Type, 2019-2028F (USD MILLION)
13.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
13.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
13.2.3. By Formulation, 2019-2028F (USD MILLION)

13.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
13.2.3.2. Patch, 2019-2028F (USD MILLION)
13.2.3.3. Spray, 2019-2028F (USD MILLION)
13.2.3.4. Gel, 2019-2028F (USD MILLION)
13.2.3.5. Others, 2019-2028F (USD MILLION)
13.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
13.2.4.1. Online, 2019-2028F (USD MILLION)
13.2.4.2. Offline, 2019-2028F (USD MILLION)
13.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
13.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
13.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
13.2.4.2.4. Others, 2019-2028F (USD MILLION)
13.2.5. By Country, 2019-2028F (USD MILLION)
13.2.5.1. UK, 2019-2028F (USD MILLION)
13.2.5.2. Germany, 2019-2028F (USD MILLION)
13.2.5.3. Italy, 2019-2028F (USD MILLION)
13.2.5.4. France, 2019-2028F (USD MILLION)
13.2.5.5. Spain, 2019-2028F (USD MILLION)
13.2.5.6. Turkey, 2019-2028F (USD MILLION)
13.2.5.7. Russia, 2019-2028F (USD MILLION)
13.2.5.8. Rest of Europe, 2019-2028F (USD MILLION)

14. Asia Pacific Topical Pain Relief Market Outlook
14.1. Macro-Economic Indicators impacting the Asia Pacific Topical Pain Relief Market
14.2. Market Size & Forecast (USD Million)
14.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
14.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
14.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
14.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
14.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
14.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
14.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
14.2.1.1.3. Others, 2019-2028F (USD MILLION)
14.2.1.2. Opioids, 2019-2028F (USD MILLION)
14.2.2. By Type, 2019-2028F (USD MILLION)
14.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
14.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
14.2.3. By Formulation, 2019-2028F (USD MILLION)
14.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
14.2.3.2. Patch, 2019-2028F (USD MILLION)
14.2.3.3. Spray, 2019-2028F (USD MILLION)

14.2.3.4. Gel, 2019-2028F (USD MILLION)
14.2.3.5. Others, 2019-2028F (USD MILLION)
14.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
14.2.4.1. Online, 2019-2028F (USD MILLION)
14.2.4.2. Offline, 2019-2028F (USD MILLION)
14.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
14.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
14.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
14.2.4.2.4. Others, 2019-2028F (USD MILLION)
14.2.5. By Country, 2019-2028F (USD MILLION)
14.2.5.1. China, 2019-2028F (USD MILLION)
14.2.5.2. India, 2019-2028F (USD MILLION)
14.2.5.3. Japan, 2019-2028F (USD MILLION)
14.2.5.4. South Korea, 2019-2028F (USD MILLION)
14.2.5.5. Australia, 2019-2028F (USD MILLION)
14.2.5.6. Rest of Asia Pacific, 2019-2028F (USD MILLION)

15. Latin America Topical Pain Relief Market Outlook
15.1. Macro-Economic Indicators impacting the Latin America Topical Pain Relief Market
15.2. Market Size & Forecast (USD Million)
15.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)

15.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
15.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
15.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
15.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
15.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
15.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
15.2.1.1.3. Others, 2019-2028F (USD MILLION)
15.2.1.2. Opioids, 2019-2028F (USD MILLION)
15.2.2. By Type, 2019-2028F (USD MILLION)
15.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
15.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
15.2.3. By Formulation, 2019-2028F (USD MILLION)
15.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
15.2.3.2. Patch, 2019-2028F (USD MILLION)
15.2.3.3. Spray, 2019-2028F (USD MILLION)
15.2.3.4. Gel, 2019-2028F (USD MILLION)
15.2.3.5. Others, 2019-2028F (USD MILLION)
15.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
15.2.4.1. Online, 2019-2028F (USD MILLION)
15.2.4.2. Offline, 2019-2028F (USD MILLION)

15.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
15.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
15.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
15.2.4.2.4. Others, 2019-2028F (USD MILLION)
15.2.5. By Country, 2019-2028F (USD MILLION)
15.2.5.1. Brazil, 2019-2028F (USD MILLION)
15.2.5.2. Mexico, 2019-2028F (USD MILLION)
15.2.5.3. Rest of Latin America, 2019-2028F (USD MILLION)

16. Middle East & Africa Topical Pain Relief Market Outlook
16.1. Macro-Economic Indicators impacting the Middle East & Africa Topical Pain Relief Market
16.2. Market Size & Forecast (USD Million)
16.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
16.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
16.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
16.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
16.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
16.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
16.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
16.2.1.1.3. Others, 2019-2028F (USD MILLION)
16.2.1.2. Opioids, 2019-2028F (USD MILLION)

16.2.2. By Type, 2019-2028F (USD MILLION)
16.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
16.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
16.2.3. By Formulation, 2019-2028F (USD MILLION)
16.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
16.2.3.2. Patch, 2019-2028F (USD MILLION)
16.2.3.3. Spray, 2019-2028F (USD MILLION)
16.2.3.4. Gel, 2019-2028F (USD MILLION)
16.2.3.5. Others, 2019-2028F (USD MILLION)
16.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
16.2.4.1. Online, 2019-2028F (USD MILLION)
16.2.4.2. Offline, 2019-2028F (USD MILLION)
16.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
16.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
16.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
16.2.4.2.4. Others, 2019-2028F (USD MILLION)
16.2.5. By Country, 2019-2028F (USD MILLION)
16.2.5.1. Israel, 2019-2028F (USD MILLION)
16.2.5.2. Saudi Arabia, 2019-2028F (USD MILLION)
16.2.5.3. UAE, 2019-2028F (USD MILLION)

16.2.5.4. South Africa, 2019-2028F (USD MILLION)
16.2.5.5. Rest of Middle East & Africa, 2019-2028F (USD MILLION)

17. Competitive Landscape
? Topical BioMedics
? Reckitt Benckiser Group plc.
? Sun Pharmaceutical Industries Ltd.
? AdvaCare Pharma
? Teikoku Pharma USA, Inc.
? Sanofi
? Johnson and Johnson
? Novartis
? Pfizer Inc.
? GlaxoSmithKline plc

18. Strategic Recommendations